{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:15:19Z","timestamp":1791994519552,"version":"4.4.0"},"reference-count":32,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Fine-needle aspiration cytology (FNAC) is the gold standard to diagnose thyroid nodules but fails in discriminating the nature of indeterminate lesions. Molecular testing can improve the diagnosis of these nodules and next-generation sequencing (NGS) can be used to test many genes simultaneously. Assess the performance of an NGS 17-gene panel on thyroid indeterminate FNAC. One hundred five indeterminate FNACs, 30.5% high-risk (TIR3B) and 69.5% low-risk (TIR3A), were analyzed by NGS. For TIR3A, the rate of mutated samples was 10.9%, significantly lower (p = 0.0001) compared to TIR3B (63.6%). Twenty-two mutated and fourteen non-mutated samples were submitted to surgery. At histology, the overall malignancy was 85.7% in the indeterminate group that had a positive molecular test and 13.3% in the mutation-negative (p = 0.01). The 17-gene panel had a sensitivity of 90%, specificity of 87%, positive predictive value (PPV) of 91%, and negative predictive value (NPV) of 87%. We reported the utility of Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults (EU-TIRADS) in selecting indeterminate nodules for molecular analysis, showing a significant correlation between US score and mutation (p = 0.004). The performance of a 17-gene panel based on NGS technology is promising, allowing the selection of indeterminate nodules to submit to surgery with a great specificity and PPV.<\/jats:p>","DOI":"10.3390\/ijms26094225","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:49:36Z","timestamp":1745912976000},"page":"4225","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic Performance of Next-Generation Sequencing (NGS) in Indeterminate Thyroid Nodules: A Single Hospital Experience"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-5831","authenticated-orcid":false,"given":"Marco","family":"Capezzone","sequence":"first","affiliation":[{"name":"UOSD of Endocrinology, Misericordia Hospital, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Rossi","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Functional Area, Hospital Misericordia, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bardi","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Functional Area, Hospital Misericordia, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia Maria","family":"Morabito","sequence":"additional","affiliation":[{"name":"UOSD of Endocrinology, Misericordia Hospital, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3238-2114","authenticated-orcid":false,"given":"Gilda","family":"Dalmazio","sequence":"additional","affiliation":[{"name":"UOSD of Endocrinology, Misericordia Hospital, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-4698","authenticated-orcid":false,"given":"Giuseppe","family":"Iapichino","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Functional Area, Hospital Misericordia, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Galassi","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Functional Area, Hospital Misericordia, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Seralessandri","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Functional Area, Hospital Misericordia, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liborio","family":"Torregrossa","sequence":"additional","affiliation":[{"name":"Department of Surgical Medical and Molecular Pathology, University Hospital of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Tosti Balducci","sequence":"additional","affiliation":[{"name":"UOSD of Endocrinology, Misericordia Hospital, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-0208","authenticated-orcid":false,"given":"Elio","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Department of Pathology, Misericordia Hospital, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Alessandri","sequence":"additional","affiliation":[{"name":"UOSD of Endocrinology, Misericordia Hospital, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5287-4250","authenticated-orcid":false,"given":"Agostino","family":"Ognibene","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Functional Area, Hospital Misericordia, 58100 Grosseto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"De Napoli","sequence":"additional","affiliation":[{"name":"Division of Endocrine Surgery, Department of Surgical Pathology, University Hospital of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3040-516X","authenticated-orcid":false,"given":"Gabriele","family":"Materazzi","sequence":"additional","affiliation":[{"name":"Division of Endocrine Surgery, Department of Surgical Pathology, University Hospital of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-295X","authenticated-orcid":false,"given":"Silvia","family":"Cantara","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Neurological Sciences, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-8249","authenticated-orcid":false,"given":"Anello Marcello","family":"Poma","sequence":"additional","affiliation":[{"name":"Department of Surgical Medical and Molecular Pathology, University Hospital of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e230067","DOI":"10.1530\/ETJ-23-0067","article-title":"2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management","volume":"12","author":"Durante","year":"2023","journal-title":"Eur. Thyroid. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cncy.22618","article-title":"The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution","volume":"130","author":"Torregrossa","year":"2022","journal-title":"Cancer Cytopathol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Biswas, S., Shah, I., Goswami, H., and Chaudhuri, A. (2025). Evaluation of concordance between the Bethesda System for Reporting Thyroid Cytopathology 2023 (TBSRTC) and ACR-TIRADS at a tertiary care center in Gujarat. Indian J. Pathol. Microbiol., 10\u20134103.","DOI":"10.4103\/ijpm.ijpm_165_24"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.semdp.2023.05.001","article-title":"Indeterminate Thyroid Nodules and Advances in Molecular Pathology","volume":"40","author":"Belovarac","year":"2023","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40618-019-01164-w","article-title":"Molecular markers for the classification of cytologically indeterminate thyroid nodules","volume":"43","author":"Muzza","year":"2020","journal-title":"J. Endocrinol. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/cncy.22332","article-title":"Diagnostic performances of the Afirma Gene Sequencing Classifier in comparison with the Gene Expression Classifier: A meta-analysis","volume":"129","author":"Vuong","year":"2021","journal-title":"Cancer Cytopathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1210\/clinem\/dgad220","article-title":"Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management","volume":"108","author":"Chiosea","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"49421","DOI":"10.18632\/oncotarget.17220","article-title":"Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology","volume":"8","author":"Sciacchitano","year":"2017","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Vignali, P., Macerola, E., Poma, A.M., Sparavelli, R., and Basolo, F. (2023). Indeterminate Thyroid Nodules: From Cytology to Molecular Testing. Diagnostics, 13.","DOI":"10.3390\/diagnostics13183008"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.6004\/jnccn.2018.0089","article-title":"NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018","volume":"16","author":"Haddad","year":"2018","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.eprac.2021.04.007","article-title":"American Association of Clinical Endocrinology and Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool","volume":"27","author":"Garber","year":"2021","journal-title":"Endocr. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40618-018-0884-2","article-title":"Italian consensus on diagnosis and treatment of differentiated thyroid cancer: Joint statements of six Italian societies","volume":"41","author":"Pacini","year":"2018","journal-title":"J. Endocrinol. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12967-016-1074-7","article-title":"Next-generation sequencing in thyroid cancer","volume":"14","author":"Cha","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_15","first-page":"e240160","article-title":"Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytology","volume":"14","author":"Potonnier","year":"2025","journal-title":"Eur. Thyroid. J."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rossi, E.D., Locantore, P., Bruno, C., Dell\u2019Aquila, M., Tralongo, P., Curatolo, M., Revelli, L., Raffaelli, M., Larocca, L.M., and Pantanowitz, L. (2022). Molecular Characterization of Thyroid Follicular Lesions in the Era of \u201cNext-Generation\u201d Techniques. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.834456"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Patel, J., Klopper, J., and Cottrill, E.E. (2023). Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1101410"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Capezzone, M., Cantara, S., Di Santo, A., Sagnella, A., Pilli, T., Brilli, L., Ciuoli, C., Maino, F., Forleo, R., and Cartocci, A. (2021). The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.613727"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1507\/endocrj.EJ21-0300","article-title":"Approach to Bethesda system category III thyroid nodules according to US-risk stratification","volume":"69","author":"Kim","year":"2022","journal-title":"Endocr. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2214\/AJR.18.20961","article-title":"Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance","volume":"213","author":"Hong","year":"2019","journal-title":"Am. J. Roentgenol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"S\u0142owi\u0144ska-Klencka, D., Klencki, M., Duda-Szyma\u0144ska, J., and Popowicz, B. (2022). Optimization of the Management of Category III Thyroid Nodules Using Repeat FNA and TIRADS. Cancers, 14.","DOI":"10.3390\/cancers14184489"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/cen.12579","article-title":"RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma","volume":"82","author":"An","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1089\/thy.2012.0640","article-title":"Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: Values of RAS mutation testing","volume":"23","author":"Lee","year":"2013","journal-title":"Thyroid"},{"key":"ref_24","first-page":"450","article-title":"RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance","volume":"34","author":"Sfreddo","year":"2024","journal-title":"Thyroid"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1089\/thy.2019.0116","article-title":"Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort","volume":"30","author":"Guan","year":"2020","journal-title":"Thyroid"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104570","DOI":"10.1016\/j.amjoto.2024.104570","article-title":"Decoding RAS mutations in thyroid cancer: A meta-analysis unveils specific links to distant metastasis and increased mortality","volume":"46","author":"Riccio","year":"2025","journal-title":"Am. J. Otolaryngol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s41669-020-00249-0","article-title":"Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?","volume":"5","author":"Pruneri","year":"2021","journal-title":"Pharmacoecon. Open"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jval.2018.06.017","article-title":"Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions","volume":"21","author":"Phillips","year":"2018","journal-title":"Value Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1530\/EJE-18-0379","article-title":"Genetics in Endocrinology: Genetic diagnosis of endocrine diseases by NGS: Novel scenarios and unpredictable results and risks","volume":"179","author":"Persani","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e00293","DOI":"10.1002\/edm2.293","article-title":"Yield and costs of molecular diagnostics on thyroid cytology slides in the Netherlands, adapting the Bethesda classification","volume":"4","author":"Aydemirli","year":"2021","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_31","first-page":"6621510","article-title":"Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer","volume":"2024","author":"Capezzone","year":"2024","journal-title":"Case Rep. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000478927","article-title":"European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS","volume":"6","author":"Russ","year":"2017","journal-title":"Eur. Thyroid. J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4225\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:24:05Z","timestamp":1760030645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26094225"],"URL":"https:\/\/doi.org\/10.3390\/ijms26094225","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}